Cardiff Oncology (CRDF) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.27
-0.24
-0.21
-0.19

Details

Expected EPS
-0.1851
Actual EPS
-0.2
Surprise EPS
-0.01
Surprise Percent
+8.05%

Description

Cardiff Oncology (CRDF) has reported earnings of -0.2 per share for Q2 2025.

0 Comments

Share your thoughts